A large systematic review and meta-analysis published in the Journal of the American Heart Association evaluated evidence from 155 studies worldwide, identifying strong associations between several viral...
Federal, professional, and state guidance on COVID-19 vaccination diverge significantly this fall. This guide synthesizes the latest recommendations to help clinicians counsel patients and ensure access.
...
New studies highlight that while persistent SARS-CoV-2 infections can evolve rapidly within individuals, they rarely spread onward. Meanwhile, the 2024–2025 COVID-19 vaccine reduced mortality by 64% among...
The Trump administration announced a new agreement with pharmaceutical companies Eli Lilly and Company and Novo Nordisk to reduce the cost of obesity medication and expand access to these treatments.
In this roundup, experts outline diverging pediatric COVID vaccine recommendations, midlife peaks in long COVID risk, new findings on abnormal uterine bleeding and cycle-related symptoms in long COVID, and...
A phase 2 nonrandomized clinical trial explored whether breast surgery could be safely eliminated for women with ERBB2-positive or triple-negative invasive breast cancer who achieved a pathologic complete...
In a randomized, placebo-controlled study, azelastine nasal spray significantly lowered the incidence of polymerase chain reaction-confirmed SARS-CoV-2 infections and reduced overall respiratory viral...
A randomized trial in breast cancer survivors found that just one session of resistance or high-intensity interval training significantly elevated circulating anti-cancer myokines and reduced the growth of...
A new study comparing robotic and laparoscopic cholecystectomies found no significant difference in perioperative opioid use or operative time between the two approaches. These findings were presented at...
